You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
BLOC1S2
Biogenesis of lysosome-related organelles complex 1 subunit 2

Protein Summary
Description
Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes (PubMed:15102850, PubMed:17182842). In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension (By similarity). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor (PubMed:25898167). May play a role in cell proliferation (PubMed:15381421). This gene encodes a protein with multiple functions. The encoded protein has been found in association with the centrosome, shown to co-localize with ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000370372
  • ENSP00000359398
  • ENSG00000196072
  • ENST00000441611
  • ENSP00000410865
  • ENST00000614731
  • ENSP00000481847

Symbol
  • BLOS2
  • CEAP
  • CEAP
  • BLOS2
  • BORCS2
  • CEAP11
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
histone modification site profile
0.85
kinase perturbation
0.84
cellular component
0.81
interacting protein
0.72
biological process
0.66


Protein Classes
No PANTHER Classes or DTO Classes found
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 40.31   (req: < 5)
Gene RIFs: 4   (req: <= 3)
Antibodies: 99   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 40.31   (req: >= 5)
Gene RIFs: 4   (req: > 3)
Antibodies: 99   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 14
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0